Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2

Abstract

BackgroundCardiovascular diseases remain a leading cause of the mortality world-wide, which is related to several risks, including the life style change and the increased diabetes prevalence. The present study was to explore the preventive effect of zinc on the pathogenic changes in the aorta.MethodsA genetic type 1 diabetic OVE26 mouse model was used with/without zinc supplementation for 3 months. To determine gender difference either for pathogenic changes in the aorta of diabetic mice or for zinc protective effects on diabetes-induced pathogenic changes, both males and females were investigated in parallel by histopathological and immunohistochemical examinations, in combination of real-time PCR assay.ResultsDiabetes induced significant increases in aortic oxidative damage, inflammation, and remodeling (increased fibrosis and wall thickness) without significant difference between genders. Zinc treatment of these diabetic mice for three months completely prevented the above pathogenic changes in the aorta, and also significantly up-regulated the expression and function of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a pivotal regulator of anti-oxidative mechanism, and the expression of metallothionein (MT), a potent antioxidant. There was gender difference for the protective effect of zinc against diabetes-induced pathogenic changes and the up-regulated levels of Nrf2 and MT in the aorta.ConclusionsThese results suggest that zinc supplementation provides a significant protection against diabetes-induced pathogenic changes in the aorta without gender difference in the type 1 diabetic mouse model. The aortic protection by zinc against diabetes-induced pathogenic changes is associated with the up-regulation of both MT and Nrf2 expression.

Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression

“…It has been widely reported that MT offers antioxidative protection from various conditions, including diabetes in our own laboratory (9,10,24,37) and in others' (39,47). We found that diabetes decreased MT expression in the heart along with pathological cardiac damage.…”

Dietary Regulation of Keap1/Nrf2/ARE Pathway: Focus on Plant-Derived Compounds and Trace Minerals

“…Interestingly, in a similar study, zinc alone completely blocked inflammation and tissue remodeling associated with T1D in the aorta. Zinc strongly upregulated Nrf2 expression and ARE target NQO1 [79]. In neural tissues, glucoraphanin, a sulforaphane precursor, upregulated Nrf2, and reduced ROS in an induced murine model of Parkinson’s disease, reducing the severity of symptoms [80].…”

Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic Inflammation

“…Overall, decreased NO bioavailability with increased production of reactive nitrogen species as reported in animal and human studies of diabetes, supports a role for platelets in diabetes-induced endothelial and pulmonary injury (Figure 3). Studies in our laboratory have previously shown that genetically-induced antioxidant pathways, such as metallothionein (MT) or Nrf 2 (nuclear factor erythroid-related factor 2) overexpression, or pharmacological induction of these pathways by zinc administration (to induce MT) or sulforaphane (to induce Nrf2) alleviate DM-induced cardiac inflammation oxidative stress and fibrosis [2,84,85,86,87,88,89]. Ongoing similar studies are in progress in our laboratory to determine the role of this pathway in inducing platelet hyperreactivity and DM-induced lung fibrosis.…”